Advanced
  Home Compare Reports

Comparison with Similar Reports

Interventional Radiology Products Market by type (Stents, Catheters, IVC Filter, Biopsy Needles, Embolization Devices, Accessories), Procedure Type (A...

Publisher:        MarketsandMarkets

# of Pages:        214

Rating: 

1 User License $4,950

Publication Date:  May, 2021

Price:       $4,950 / User License




1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 26
1.3 MARKET SCOPE 27
FIGURE 1 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SEGMENTATION 27
1.3.1 YEARS CONSIDERED FOR THE STUDY 27
1.4 CURRENCY 28
1.5 LIMITATIONS 28
1.6 STAKEHOLDERS 28
1.7 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
FIGURE 2 RESEARCH DESIGN 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Secondary sources 31
2.1.2 PRIMARY DATA 32
FIGURE 3 PRIMARY SOURCES 32
2.1.2.1 Key data from primary sources 33
2.1.2.2 Key industry insights 34
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 34
2.2 MARKET SIZE ESTIMATION 35
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 35
2.2.1 GROWTH FORECAST 36
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 36
FIGURE 7 TOP-DOWN APPROACH 37
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 38
FIGURE 8 DATA TRIANGULATION METHODOLOGY 38
2.4 ASSUMPTIONS FOR THE STUDY 39
2.5 COVID-19 ECONOMIC ASSESSMENT 39
2.6 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 40
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY 40
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 41
3 EXECUTIVE SUMMARY 42
FIGURE 11 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 42
FIGURE 12 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE,
2021 VS. 2026 (USD MILLION) 43
FIGURE 13 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 43
FIGURE 14 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY REGION,
2021 VS. 2026 (USD MILLION) 44
4 PREMIUM INSIGHTS 45
4.1 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET OVERVIEW 45
FIGURE 15 INCREASING INCIDENCE OF CHRONIC DISORDERS TO DRIVE MARKET GROWTH 45
4.2 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE (2021–2026) 46
FIGURE 16 STENTS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 46
4.3 NORTH AMERICA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY TYPE AND COUNTRY (2020) 47
FIGURE 17 THE US DOMINATED THE NORTH AMERICAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET IN 2020 47
4.4 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 48
FIGURE 18 INDIA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
FIGURE 19 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
5.2.1 DRIVERS 49
5.2.1.1 Rising prevalence of chronic diseases 49
5.2.1.2 Growing geriatric population 50
5.2.1.3 Increasing demand for minimally invasive procedures 51
5.2.1.4 Favorable reimbursement scenario for interventional radiology procedures 51
TABLE 1 REIMBURSEMENT FOR INTERVENTIONAL RADIOLOGY PROCEDURES IN
THE US 51
5.2.2 RESTRAINTS 52
5.2.2.1 Availability of effective conventional first-level treatments 52
5.2.2.2 High cost and inaccessibility of advanced therapeutics 52
5.2.3 OPPORTUNITIES 52
5.2.3.1 Emerging markets 52
5.2.4 CHALLENGES 53
5.2.4.1 Entry barriers for new players 53
5.2.4.2 Product failures and recalls 53
5.3 REGULATORY LANDSCAPE 53
5.4 COVID-19 IMPACT ON THE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET 54
5.5 TECHNOLOGY ANALYSIS 55
5.6 PRICING ANALYSIS 55
TABLE 2 PRICES OF INTERVENTIONAL RADIOLOGY PRODUCTS 55
5.7 TRADE ANALYSIS 56
TABLE 3 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SERVICES, BY COUNTRY,
2016-2020 (USD MILLION) 56
TABLE 4 EXPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SERVICES, BY COUNTRY,
2016-2020 (USD MILLION) 56
TABLE 5 IMPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY PROCEDURES, BY COUNTRY, 2016-2020 (USD MILLION) 57
TABLE 6 EXPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY PROCEDURES, BY COUNTRY, 2016-2020 (USD MILLION) 57
5.8 PATENT ANALYSIS 58
5.9 VALUE CHAIN ANALYSIS 58
FIGURE 20 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES 59
5.10 SUPPLY CHAIN ANALYSIS 59
FIGURE 21 DIRECT DISTRIBUTION: A STRATEGY PREFERRED BY PROMINENT COMPANIES 60
5.11 ECOSYSTEM ANALYSIS 61
5.11.1 ROLE IN THE ECOSYSTEM 62
TABLE 7 ROLE IN THE ECOSYSTEM 62
5.12 PORTER’S FIVE FORCES ANALYSIS 62
TABLE 8 PORTER’S FIVE FORCES 62
5.12.1 DEGREE OF COMPETITION 63
5.12.2 BARGAINING POWER OF SUPPLIERS 63
5.12.3 BARGAINING POWER OF BUYERS 63
5.12.4 THREAT OF SUBSTITUTES 63
5.12.5 THREAT OF NEW ENTRANTS 63
5.13 YCC SHIFT 64
6 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE 65
6.1 INTRODUCTION 66
TABLE 9 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 66
6.2 STENTS 66
6.2.1 INCREASING ADOPTION OF DRUG-ELUTING STENTS AND BIOABSORBABLE STENTS—A KEY FACTOR DRIVING MARKET GROWTH 66
TABLE 10 INTERVENTIONAL RADIOLOGY STENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 67
6.3 CATHETERS 67
TABLE 11 INTERVENTIONAL RADIOLOGY CATHETERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 67
TABLE 12 INTERVENTIONAL RADIOLOGY CATHETERS MARKET, BY REGION,
2019–2026 (USD MILLION) 68
6.3.1 DIAGNOSTIC CATHETERS 68
6.3.1.1 Diagnostic catheters held the largest share of the interventional radiology catheters market 68
TABLE 13 INTERVENTIONAL RADIOLOGY DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019–2026 (USD MILLION) 68
6.3.2 THERAPEUTIC CATHETERS 69
6.3.2.1 Increasing adoption of minimally invasive therapeutic procedures to drive market growth 69
TABLE 14 INTERVENTIONAL RADIOLOGY THERAPEUTIC CATHETERS MARKET,
BY REGION, 2019–2026 (USD MILLION) 69
6.4 INFERIOR VENA CAVA FILTERS 69
6.4.1 INCREASING PREVALENCE OF PULMONARY EMBOLISM TO DRIVE MARKET GROWTH 69
TABLE 15 INTERVENTIONAL RADIOLOGY INFERIOR VENA CAVA FILTERS MARKET,
BY REGION, 2019–2026 (USD MILLION) 70
6.5 HEMODYNAMIC FLOW ALTERATION DEVICES 70
6.5.1 RISING NUMBER OF REGULATORY APPROVALS AND TECHNOLOGICAL ADVANCEMENTS TO FAVOR MARKET GROWTH 70
TABLE 16 INTERVENTIONAL RADIOLOGY HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 71
6.6 ANGIOPLASTY BALLOONS 71
6.6.1 RISING NUMBER OF REGULATORY APPROVALS FOR ANGIOPLASTY BALLOONS TO SUPPORT MARKET GROWTH 71
TABLE 17 INTERVENTIONAL RADIOLOGY ANGIOPLASTY BALLOONS MARKET,
BY REGION, 2019–2026 (USD MILLION) 72
6.7 THROMBECTOMY SYSTEMS 72
6.7.1 INCREASING NUMBER OF PRODUCT INNOVATIONS AND APPROVALS TO AID MARKET GROWTH 72
TABLE 18 INTERVENTIONAL RADIOLOGY THROMBECTOMY SYSTEMS MARKET,
BY REGION, 2019–2026 (USD MILLION) 72
6.8 EMBOLIZATION DEVICES 73
6.8.1 INCREASING INCIDENCE OF AORTIC ANEURYSMS IS A KEY FACTOR DRIVING MARKET GROWTH 73
TABLE 19 INTERVENTIONAL RADIOLOGY EMBOLIZATION DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 73
6.9 BIOPSY NEEDLES 73
6.9.1 RISING PREVALENCE OF CANCER TO DRIVE THE ADOPTION OF BIOPSY NEEDLE PROCEDURES 73
TABLE 20 INTERVENTIONAL RADIOLOGY BIOPSY NEEDLES MARKET, BY REGION,
2019–2026 (USD MILLION) 74
6.10 ACCESSORIES 74
TABLE 21 INTERVENTIONAL RADIOLOGY ACCESSORIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 74
TABLE 22 INTERVENTIONAL RADIOLOGY ACCESSORIES MARKET, BY REGION,
2019–2026 (USD MILLION) 75
6.10.1 CONTRAST MEDIA 75
6.10.1.1 Contrast media segment held the largest share of the interventional radiology accessories market 75
TABLE 23 INTERVENTIONAL RADIOLOGY CONTRAST MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 75
6.10.2 GUIDEWIRES 76
6.10.2.1 Rising number of surgical procedures to favor market growth 76
TABLE 24 INTERVENTIONAL RADIOLOGY GUIDEWIRES MARKET, BY REGION,
2019–2026 (USD MILLION) 76
6.10.3 BALLOON INFLATION DEVICES 76
6.10.3.1 Growth in the number of angioplasty procedures to drive the demand for balloon inflation devices 76
TABLE 25 INTERVENTIONAL RADIOLOGY BALLOON INFLATION DEVICES MARKET,
BY REGION, 2019–2026 (USD MILLION) 77
6.10.4 OTHER ACCESSORIES 77
TABLE 26 INTERVENTIONAL RADIOLOGY MARKET FOR OTHER ACCESSORIES,
BY REGION, 2019–2026 (USD MILLION) 77
6.11 OTHER INTERVENTIONAL RADIOLOGY PRODUCTS 77
TABLE 27 OTHER INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY REGION, 2019–2026 (USD MILLION) 78
7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE 79
7.1 INTRODUCTION 80
TABLE 28 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 80
7.2 ANGIOGRAPHY 80
7.2.1 ANGIOGRAPHY IS THE LARGEST & FASTEST-GROWING SEGMENT OF
THE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET 80
TABLE 29 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR ANGIOGRAPHY,
BY REGION, 2019–2026 (USD MILLION) 81
7.3 ANGIOPLASTY 81
7.3.1 RISING PREVALENCE OF STROKE TO DRIVE MARKET GROWTH 81
TABLE 30 NUMBER OF TRANSLUMINAL CORONARY ANGIOPLASTY PROCEDURES PERFORMED, BY COUNTRY, 2015 VS. 2018 81
TABLE 31 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR ANGIOPLASTY,
BY REGION, 2019–2026 (USD MILLION) 82
7.4 BIOPSY & DRAINAGE 82
7.4.1 RISING PREVALENCE OF CANCER HAS INCREASED THE DEMAND FOR BIOPSY & DRAINAGE PROCEDURES 82
TABLE 32 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR BIOPSY & DRAINAGE, BY REGION, 2019–2026 (USD MILLION) 82
7.5 EMBOLIZATION 83
7.5.1 INCREASING DEMAND FOR EMBOLIZATION IN THE TREATMENT OF FIBROIDS TO DRIVE MARKET GROWTH 83
TABLE 33 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR EMBOLIZATION,
BY REGION, 2019–2026 (USD MILLION) 83
7.6 THROMBOLYSIS 83
7.6.1 RISING PREVALENCE OF DVT TO DRIVE MARKET GROWTH 83
TABLE 34 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR THROMBOLYSIS,
BY REGION, 2019–2026 (USD MILLION) 84
7.7 VERTEBROPLASTY 84
7.7.1 INCREASING CASES OF OSTEOPOROSIS TO DRIVE THE DEMAND FOR VERTEBROPLASTY PROCEDURES 84
TABLE 35 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR VERTEBROPLASTY,
BY REGION, 2019–2026 (USD MILLION) 84
7.8 NEPHROSTOMY 85
7.8.1 INCREASING PREVALENCE OF KIDNEY DISEASES TO SUPPORT MARKET GROWTH 85
TABLE 36 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR NEPHROSTOMY,
BY REGION, 2019–2026 (USD MILLION) 85
7.9 OTHER PROCEDURES 85
TABLE 37 NUMBER OF CHOLECYSTECTOMY PROCEDURES PERFORMED, BY COUNTRY, 2015 VS. 2018 86
TABLE 38 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR OTHER PROCEDURES, BY REGION, 2019–2026 (USD MILLION) 86
8 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION 87
8.1 INTRODUCTION 88
TABLE 39 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 88
8.2 CARDIOLOGY 88
8.2.1 CARDIOLOGY IS THE LARGEST APPLICATION SEGMENT OF THE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET 88
TABLE 40 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR CARDIOLOGY,
BY REGION, 2019–2026 (USD MILLION) 89
8.3 UROLOGY & NEPHROLOGY 89
8.3.1 INNOVATION AND DEVELOPMENT OF PRODUCTS LIKE DRAINAGE CATHETERS TO SUPPORT MARKET GROWTH 89
TABLE 41 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR UROLOGY & NEPHROLOGY, BY REGION, 2019–2026 (USD MILLION) 90
8.4 ONCOLOGY 90
8.4.1 ONCOLOGY IS THE FASTEST-GROWING APPLICATION SEGMENT IN
THE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET 90
TABLE 42 INCREASING INCIDENCE OF CANCER, BY REGION,
2020 VS. 2030 VS. 2040 (MILLION) 90
TABLE 43 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR ONCOLOGY,
BY REGION, 2019–2026 (USD MILLION) 91
8.5 GASTROENTEROLOGY 91
8.5.1 HIGH INCIDENCE OF GASTROINTESTINAL DISORDERS TO DRIVE MARKET GROWTH 91
TABLE 44 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR GASTROENTEROLOGY, BY REGION, 2019–2026 (USD MILLION) 92
8.6 NEUROLOGY 92
8.6.1 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH 92
TABLE 45 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR NEUROLOGY,
BY REGION, 2019–2026 (USD MILLION) 92
8.7 ORTHOPEDICS 93
8.7.1 RISING GERIATRIC POPULATION TO AID THE GROWTH OF THIS MARKET 93
TABLE 46 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR ORTHOPEDICS,
BY REGION, 2019–2026 (USD MILLION) 93
8.8 OTHER APPLICATIONS 93
TABLE 47 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 93
9 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY REGION 94
9.1 INTRODUCTION 95
TABLE 48 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY REGION,
2019–2026 (USD MILLION) 95
9.2 NORTH AMERICA 96
FIGURE 22 NORTH AMERICA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SNAPSHOT 96
TABLE 49 NORTH AMERICA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 97
TABLE 50 NORTH AMERICA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 97
TABLE 51 NORTH AMERICA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY PROCEDURE, 2019–2026 (USD MILLION) 98
TABLE 52 NORTH AMERICA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 98
9.2.1 US 99
9.2.1.1 The US dominates the North American interventional radiology products market 99
TABLE 53 US: KEY MACROINDICATORS 99
TABLE 54 US: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 100
TABLE 55 US: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 100
TABLE 56 US: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 101
9.2.2 CANADA 101
9.2.2.1 High burden of target diseases to drive the market in Canada 101
TABLE 57 CANADA: KEY MACROINDICATORS 101
TABLE 58 CANADA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 102
TABLE 59 CANADA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY PROCEDURE, 2019–2026 (USD MILLION) 102
TABLE 60 CANADA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 103
9.3 EUROPE 103
TABLE 61 NUMBER OF SURGICAL PROCEDURES PER 100,000 POPULATION,
BY COUNTRY, 2018 103
TABLE 62 EUROPE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 104
TABLE 63 EUROPE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 104
TABLE 64 EUROPE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY PROCEDURE, 2019–2026 (USD MILLION) 105
TABLE 65 EUROPE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 105
9.3.1 GERMANY 106
9.3.1.1 Germany held the largest share of the European market in 2020 106
TABLE 66 GERMANY: KEY MACROINDICATORS 106
TABLE 67 GERMANY: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 107
TABLE 68 GERMANY: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY PROCEDURE, 2019–2026 (USD MILLION) 107
TABLE 69 GERMANY: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 108
9.3.2 UK 108
9.3.2.1 Government insurance schemes to support market growth 108
TABLE 70 UK: KEY MACROINDICATORS 109
TABLE 71 UK: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 109
TABLE 72 UK: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 110
TABLE 73 UK: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 110
9.3.3 FRANCE 111
9.3.3.1 Large number of interventional radiology procedures to propel market growth 111
TABLE 74 FRANCE: KEY MACROINDICATORS 111
TABLE 75 FRANCE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 112
TABLE 76 FRANCE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY PROCEDURE, 2019–2026 (USD MILLION) 112
TABLE 77 FRANCE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 113
9.3.4 ITALY 113
9.3.4.1 Rising geriatric population in the country to support the market growth 113
TABLE 78 ITALY: KEY MACROINDICATORS 113
TABLE 79 ITALY: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 114
TABLE 80 ITALY: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 114
TABLE 81 ITALY: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 115
9.3.5 REST OF EUROPE (ROE) 115
TABLE 82 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP) 115
TABLE 83 ROE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 116
TABLE 84 ROE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 116
TABLE 85 ROE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 117
9.4 ASIA PACIFIC 117
FIGURE 23 ASIA PACIFIC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SNAPSHOT 118
TABLE 86 ASIA PACIFIC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 119
TABLE 87 ASIA PACIFIC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 119
TABLE 88 ASIA PACIFIC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY PROCEDURE, 2019–2026 (USD MILLION) 120
TABLE 89 ASIA PACIFIC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 120
9.4.1 JAPAN 121
9.4.1.1 Japan accounted for the largest share of the APAC market in 2020 121
TABLE 90 JAPAN: KEY INDICATORS 121
TABLE 91 JAPAN: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 122
TABLE 92 JAPAN: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 122
TABLE 93 JAPAN: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 123
9.4.2 CHINA 123
9.4.2.1 High tobacco consumption to favor market growth 123
TABLE 94 CHINA: ESTIMATED ANNUAL DES VOLUME AND NUMBER OF CLASS III HOSPITALS, BY CITY (2019) 124
TABLE 95 CHINA: KEY INDICATORS 124
TABLE 96 CHINA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 97 CHINA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 125
TABLE 98 CHINA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 126
9.4.3 INDIA 126
9.4.3.1 Improving healthcare infrastructure and rising number of hospitals to support market growth in India 126
TABLE 99 INDIA: KEY INDICATORS 126
TABLE 100 INDIA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 127
TABLE 101 INDIA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 127
TABLE 102 INDIA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 128
9.4.4 REST OF ASIA PACIFIC (ROAPAC) 128
TABLE 103 ROAPAC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 129
TABLE 104 ROAPAC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 129
TABLE 105 ROAPAC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 130
9.5 REST OF THE WORLD (ROW) 130
TABLE 106 ROW: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 107 ROW: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 131
TABLE 108 ROW: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 132
10 COMPETITIVE LANDSCAPE 133
10.1 OVERVIEW 133
FIGURE 24 KEY DEVELOPMENTS IN THE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, JANUARY 2018–APRIL 2021 133
10.2 MARKET SHARE ANALYSIS 134
TABLE 109 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET: DEGREE OF COMPETITION (2020) 134
10.3 COMPANY EVALUATION QUADRANT 135
10.3.1 STARS 135
10.3.2 EMERGING LEADERS 135
10.3.3 PERVASIVE PLAYERS 135
10.3.4 PARTICIPANTS 135
FIGURE 25 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET: COMPANY EVALUATION QUADRANT, 2020 136
10.4 COMPANY EVALUATION QUADRANT FOR SME/START-UPS 137
10.4.1 PROGRESSIVE COMPANIES 137
10.4.2 STARTING BLOCKS 137
10.4.3 RESPONSIVE COMPANIES 137
10.4.4 DYNAMIC COMPANIES 137
FIGURE 26 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET: COMPANY EVALUATION QUADRANT FOR SME & START-UPS, 2020 138
10.5 COMPETITIVE SCENARIO 139
FIGURE 27 MARKET EVALUATION MATRIX, 2018–2021 139
10.5.1 DEALS 139
TABLE 110 DEALS 139
10.5.2 PRODUCT LAUNCHES 140
TABLE 111 PRODUCT LAUNCHES 140
10.5.3 OTHER DEVELOPMENTS 141
TABLE 112 OTHER DEVELOPMENTS 141
 
10.6 COMPANY PRODUCT FOOTPRINT 142
TABLE 113 COMPANY FOOTPRINT 142
FIGURE 28 COMPANY PRODUCT FOOTPRINT 144
FIGURE 29 COMPANY APPLICATION FOOTPRINT 145
TABLE 114 COMPANY GEOGRAPHICAL FOOTPRINT 146
11 COMPANY PROFILES 147
11.1 KEY PLAYERS 147
(Business Overview, Products/Services/Solutions Offered, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 MEDTRONIC PLC 147
TABLE 115 MEDTRONIC: BUSINESS OVERVIEW 147
FIGURE 30 MEDTRONIC: COMPANY SNAPSHOT (2020) 148
11.1.2 BOSTON SCIENTIFIC CORPORATION 152
TABLE 116 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 152
FIGURE 31 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020) 153
11.1.3 BECTON, DICKINSON AND COMPANY 157
TABLE 117 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 157
FIGURE 32 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020) 158
11.1.4 ABBOTT 161
TABLE 118 ABBOTT: BUSINESS OVERVIEW 161
FIGURE 33 ABBOTT: COMPANY SNAPSHOT (2020) 162
11.1.5 CARDINAL HEALTH 165
TABLE 119 CARDINAL HEALTH: BUSINESS OVERVIEW 165
FIGURE 34 CARDINAL HEALTH: COMPANY SNAPSHOT (2020) 166
11.1.6 B. BRAUN MELSUNGEN AG 168
TABLE 120 B. BRAUN MELSUNGEN: BUSINESS OVERVIEW 168
FIGURE 35 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020) 169
TABLE 121 EXCHANGE RATES USED FOR THE CONVERSION OF EUR TO USD 169
11.1.7 STRYKER 173
TABLE 122 STRYKER: BUSINESS OVERVIEW 173
FIGURE 36 STRYKER: COMPANY SNAPSHOT (2020) 173
11.1.8 TERUMO MEDICAL CORPORATION 176
TABLE 123 TERUMO MEDICAL CORPORATION: BUSINESS OVERVIEW 176
FIGURE 37 TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT (2019) 176
TABLE 124 EXCHANGE RATES USED FOR THE CONVERSION OF JPY TO USD 177
11.1.9 COOK MEDICAL 179
TABLE 125 COOK MEDICAL: BUSINESS OVERVIEW 179
11.1.10 BIOSENSORS INTERNATIONAL GROUP, LTD. 182
TABLE 126 BIOSENSORS INTERNATIONAL GROUP, LTD.: BUSINESS OVERVIEW 182
11.1.11 TELEFLEX INCORPORATED 184
TABLE 127 TELEFLEX INCORPORATED: BUSINESS OVERVIEW 184
FIGURE 38 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2020) 184
11.1.12 IVASCULAR S.L.U. 186
TABLE 128 IVASCULAR S.L.U.: BUSINESS OVERVIEW 186
11.1.13 PENUMBRA, INC. 188
TABLE 129 PENUMBRA, INC.: BUSINESS OVERVIEW 188
FIGURE 39 PENUMBRA, INC.: COMPANY SNAPSHOT (2020) 188
11.1.14 BIOTRONIK SE & CO. KG 191
TABLE 130 BIOTRONIK SE & CO. KG: BUSINESS OVERVIEW 191
11.1.15 ENDOCOR GMBH 194
TABLE 131 ENDOCOR GMBH: BUSINESS OVERVIEW 194
11.1.16 MERIL LIFE SCIENCES PVT. LTD. 196
TABLE 132 MERIL LIFE SCIENCES PVT. LTD.: BUSINESS OVERVIEW 196
11.2 OTHER PLAYERS 198
11.2.1 PALEX MEDICAL SA 198
11.2.2 URESIL, LLC 199
11.2.3 ALVIMEDICA 200
11.2.4 CARDIONOVUM GMBH 202
11.2.5 SMT 203
11.2.6 MEDINOL LTD. 205
11.2.7 COMED B.V. 206
11.2.8 SCITECH 207
11.2.9 BALTON SP. Z O.O. 208
11.2.10 RONTIS CORPORATION 209
*Business Overview, Products/Services/Solutions Offered, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12 APPENDIX 211
12.1 INSIGHTS FROM INDUSTRY EXPERTS 211
12.2 DISCUSSION GUIDE 212
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 216
12.4 AVAILABLE CUSTOMIZATIONS 218
12.5 RELATED REPORTS 218
12.6 AUTHOR DETAILS 219

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127